IL-2 datasheet

Recombinant Human Interleukin-2 (IL2)
(Cat. No.: C013)

Background:
    In vitro studies performed on human cell lines demonstrate the immunoregulatory properties of IL-2 including: 1) enhancement of lymphocyte mitogenesis and stimulation of long-term growth of human IL-2 dependent cell lines; 2) enhancement of lymphocyte cytotoxicity; 3) induction of killer cell (lymphokine-activated (LAK) and natural (NK)) activity; 4) deduction of interferon-gamma production.

Description:
    Recombinant Human interleukin-2 is a highly purified protein with a molecular weight of approximately 15,300 Daltons. The chemical name is des-alanyl-1, serine-125 human interleukin-2. It is produced by recombinant DNA technology using a genetically engineered E. coli strain containing an analog of the human interleukin-2 gene. Genetic engineering techniques were used to modify the human IL-2 gene, and the resulting expression clone encodes a modified human IL-2. This recombinant form differs from native interleukin-2 in following ways: 1) it is not glycosylated; 2) the molecule has no N-terminal alanine; 3) the molecule has serine substituted for cysteine at amino acid position 125; 4) the aggregation state of molecule is likely to be different from that of native IL-2.

Quality Control:
    Biological activity: The specific activity as determined and was found to be greater than 1.0 x 10⁷ IU/ mg.
    Purity: Greater than 95% as determined by
                (a) Analysis by SEC-HPLC.
                (b) Analysis by reducing and non-reducing SDS-PAGE Silver Stained gel.
    Isoelectric Point: the main zone between 6.5~7.5 analysis by IEF.
    Amino-Acid Sequence: The sequence of the first fifteen N-terminal amino acids was determined and was found to be Met-Ala-Pro-Thr-Ser-Ser-Ser-Thr-Lys-Lys-Thr-Gln-Leu- Gln-Leu-Glu.
    Endotoxin: Less than 0.1ng/µg (0.1IEU/µg) determined by LAL test.

Formulation: The protein (1.1mg/ml) was lyophilized after extensive dialysis against 0.17mg sodium monobasic & 0.89mg dibasic sodium phosphate buffer to a pH=7.5. 

Storage: Lyophilized rHuIL-2 although stable at room temperature for 3 weeks, should be stored desiccated below -18^oC. Upon reconstitution rHuIL-2 should be stored at 4^oC between 2-7 days and for future use below -18^oC. For long-term storage it is recommended to add a carrier protein (0.1% HSA or BSA).
    Please avoid freeze-thaw cycles. 

Reconstitution: It is recommended to reconstitute the lyophilized rHuIL-2 in sterile 18M¦¸-cm H₂O not less than 100µg/ml, which can then be further diluted to other aqueous solutions.